−0.070CAD
−7.72 MCAD
5.07 MCAD
88.01 M
About RAMM PHARMA CORP.
Sector
CEO
Jackie Peter Burnett
Headquarters
Toronto
Website
Founded
1988
FIGI
BBG00QS5KZT9
RAMM Pharma Corp. engages in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It offers Epifractan and CannabiPiel. The company was founded in 1988 and is headquartered in Toronto, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RAMM is 0.060 CAD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange RAMM PHARMA CORP. stocks are traded under the ticker RAMM.
RAMM stock is 0% volatile and has beta coefficient of 1.87. Check out the list of the most volatile stocks — is RAMM PHARMA CORP. there?
Yes, you can track RAMM PHARMA CORP. financials in yearly and quarterly reports right on TradingView.
RAMM net income for the last quarter is −2.29 M CAD, while the quarter before that showed −3.85 M CAD of net income which accounts for 40.52% change. Track more RAMM PHARMA CORP. financial stats to get the full picture.
Today RAMM PHARMA CORP. has the market capitalization of 7.16 M, it has decreased by 29.41% over the last week.
No, RAMM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RAMM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RAMM PHARMA CORP. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RAMM PHARMA CORP. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RAMM PHARMA CORP. stock shows the sell signal. See more of RAMM PHARMA CORP. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RAMM PHARMA CORP. EBITDA is −5.50 M CAD, and current EBITDA margin is −113.14%. See more stats in RAMM PHARMA CORP. financial statements.